Correlation Between Pfizer and Marker Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pfizer and Marker Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Marker Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Marker Therapeutics, you can compare the effects of market volatilities on Pfizer and Marker Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Marker Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Marker Therapeutics.
Diversification Opportunities for Pfizer and Marker Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pfizer and Marker is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Marker Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marker Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Marker Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marker Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and Marker Therapeutics go up and down completely randomly.
Pair Corralation between Pfizer and Marker Therapeutics
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Marker Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 4.14 times less risky than Marker Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Marker Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 425.00 in Marker Therapeutics on September 14, 2024 and sell it today you would earn a total of 19.00 from holding Marker Therapeutics or generate 4.47% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Marker Therapeutics
Performance |
Timeline |
Pfizer Inc |
Marker Therapeutics |
Pfizer and Marker Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Marker Therapeutics
The main advantage of trading using opposite Pfizer and Marker Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Marker Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will offset losses from the drop in Marker Therapeutics' long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
Marker Therapeutics vs. Lumos Pharma | Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |